|
1
|
American Diabetes Association: Standards
of medical care in diabetes - 2014. Diabetes Care. 37 (Suppl
1):S14–S80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pai LW, Hung CT, Li SF, Chen LL, Chung Y
and Liu HL: Musculoskeletal pain in people with and without type 2
diabetes in Taiwan: A population-based, retrospective cohort study.
BMC Musculoskelet Disord. 16:3642015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 32 (Suppl
1):S62–S67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, York NW, Nichols CG and Remedi MS:
Pancreatic β cell dedifferentiation in diabetes and
redifferentiation following insulin therapy. Cell Metab.
19:872–882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kendall DM, Riddle MC, Rosenstock J,
Zhuang D, Kim DD, Fineman MS and Baron AD: Effects of exenatide
(exendin-4) on glycemic control over 30 weeks in patients with type
2 diabetes treated with metformin and a sulfonylurea. Diabetes
Care. 28:1083–1091. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tate M, Robinson E, Green BD, McDermott BJ
and Grieve DJ: Exendin-4 attenuates adverse cardiac remodelling in
streptozocin-induced diabetes via specific actions on infiltrating
macrophages. Basic Res Cardiol. 111:12016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ortega FJ, Mercader JM, Moreno-Navarrete
JM, Rovira O, Guerra E, Esteve E, Xifra G, Martínez C, Ricart W,
Rieusset J, et al: Profiling of circulating microRNAs reveals
common microRNAs linked to type 2 diabetes that change with insulin
sensitization. Diabetes Care. 37:1375–1383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lima TI, Araujo HN, Menezes ES, Sponton
CH, Araújo MB, Bomfim LH, Queiroz AL, Passos MA, E Sousa TA,
Hirabara SM, et al: Role of microRNAs on the regulation of
mitochondrial biogenesis and insulin signaling in skeletal muscle.
J Cell Physiol. 232:958–966. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jia Y, Zheng Z, Guan M, Zhang Q, Li Y,
Wang L and Xue Y: Exendin-4 ameliorates high glucose-induced
fibrosis by inhibiting the secretion of miR-192 from injured renal
tubular epithelial cells. Exp Mol Med. 50:562018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo C, Sun YQ, Li Q and Zhang JC: MiR-7,
miR-9 and miR-375 contribute to effect of Exendin-4 on pancreatic
β-cells in high-fat-diet-fed mice. Clin Invest Med. 41:E16–E24.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yao Y, Li Q, Wang W, Zhang J, Gao P and Xu
Y: Glucagon-like peptide-1 modulates cholesterol homeostasis by
suppressing the miR-19b-induced downregulation of ABCA1. Cell
Physiol Biochem. 50:679–693. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou J, Chu J, Wang YH, Wang H, Zhuang YP
and Zhang SL: Purification and bioactivity of exendin-4, a peptide
analogue of GLP-1, expressed in Pichia pastoris. Biotechnol Lett.
30:651–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
NCD Risk Factor Collaboration (NCD-RisC),
. Worldwide trends in diabetes since 1980: A pooled analysis of 751
population-based studies with 4.4 million participants. Lancet.
387:1513–1530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nolan CJ, Ruderman NB, Kahn SE, Pedersen O
and Prentki M: Insulin resistance as a physiological defense
against metabolic stress: Implications for the management of
subsets of type 2 diabetes. Diabetes. 64:673–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jung HS, Chung KW, Won Kim J, Kim J,
Komatsu M, Tanaka K, Nguyen YH, Kang TM, Yoon KH, Kim JW, et al:
Loss of autophagy diminishes pancreatic beta cell mass and function
with resultant hyperglycemia. Cell Metab. 8:318–324. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miller KM, Foster NC, Beck RW, Bergenstal
RM, DuBose SN, DiMeglio LA, Maahs DM and Tamborlane WV; T1D
Exchange Clinic Network, : Current state of type 1 diabetes
treatment in the U.S.: Updated data from the T1D Exchange clinic
registry. Diabetes Care. 38:971–978. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ceriello A, La Sala L, De Nigris V,
Pujadas G, Rondinelli M and Genovese S: GLP-1 reduces
metalloproteinase-9 induced by both hyperglycemia and hypoglycemia
in type 1 diabetes. The possible role of oxidative stress. Ther
Clin Risk Manag. 11:901–903. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li C, Hou S, Liu S, Huan Y, Sun S, Liu Q
and Shen Z: The albumin-exendin-4 recombinant protein E2HSA
improves glycemic control and β-cell function in spontaneous
diabetic KKAy mice. BMC Pharmacol Toxicol. 18:482017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Candeias E, Sebastião I, Cardoso S,
Carvalho C, Santos MS, Oliveira CR, Moreira PI and Duarte AI: Brain
GLP-1/IGF-1 signaling and autophagy mediate exendin-4 protection
against apoptosis in type 2 diabetic rats. Mol Neurobiol.
55:4030–4050. 2018.PubMed/NCBI
|
|
21
|
He JS, Lian CW, Fang YL, Wu JZ, Ye XL and
Zhu SB: Influence and significance of intervening diabetes microRNA
expression profile of NOD mice with exendin-4. Eur Rev Med
Pharmacol Sci. 20:4322–4327. 2016.PubMed/NCBI
|
|
22
|
Jo S, Chen J, Xu G, Grayson TB, Thielen LA
and Shalev A: miR-204 controls glucagon-like peptide 1 receptor
expression and agonist function. Diabetes. 67:256–264. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li PC, Liu LF, Jou MJ and Wang HK: The
GLP-1 receptor agonists exendin-4 and liraglutide alleviate
oxidative stress and cognitive and micturition deficits induced by
middle cerebral artery occlusion in diabetic mice. BMC Neurosci.
17:372016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seo E, Lim JS, Jun JB, Choi W, Hong IS and
Jun HS: Exendin-4 in combination with adipose-derived stem cells
promotes angiogenesis and improves diabetic wound healing. J Transl
Med. 15:352017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lehtonen J, Schäffer L, Rasch MG,
Hecksher-Sørensen J and Ahnfelt-Rønne J: Beta cell specific probing
with fluorescent exendin-4 is progressively reduced in type 2
diabetic mouse models. Islets. 7:e11374152015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lotta LA, Sharp SJ, Burgess S, Perry JRB,
Stewart ID, Willems SM, Luan J, Ardanaz E, Arriola L, Balkau B, et
al: Association between low-density lipoprotein
cholesterol-lowering genetic variants and risk of type 2 diabetes:
A Meta-analysis. JAMA. 316:1383–1391. 2016. View Article : Google Scholar : PubMed/NCBI
|
